Entering German and European healthcare means navigating different rules, payers and decision‑makers – so even strong solutions stall in pilots or single flagship sites.
Without trusted access to leading clinics, KOLs and payers, it is hard to test assumptions, generate proof and build a credible case for adoption.
Strategies and decks rarely translate into day‑to‑day change; internal teams lack local experience to drive execution.
You get evidence- and economics‑driven pathways that show exactly how your solution can enter routine care across markets.
We open doors to clinicians, KOLs, payers and partners and co‑create your case with them instead of pitching from the outside.
You work directly with hands‑on senior experts who stay involved from clinical validation and reimbursement strategy to go‑to‑market, partnering and scaling – until your solution works in routine care.
We connect all key stakeholders in the ecosystem – clinicians, payers, partners and investors – so that promising solutions find their place in everyday care faster.
We target leading hospitals and clinics to secure clinical validation and create your first reference customers.
We align product, clinical communication, marketing and technology with local requirements.
We drive training and peer‑to‑peer exchange to achieve clinical and market success.
We accelerate go‑to‑market via partners, targeted publications and strong KOL advocacy.
Leave your details and we’ll be in touch soon to explore if and how a collaboration with us can accelerate your next steps in the German healthcare market.
As mediq Innovation Experts, we partner with health‑tech founders who want more than generic advice – they need a sparring partner who understands both innovation and the realities of the German healthcare system. Explore how we support you from first market exploration to clinical validation, reimbursement and commercial scale‑up.
Our mediq Market Readiness Kit helps you assess your opportunity in the German healthcare market by clarifying market structure, competition, regulatory requirements, reimbursement potential, and procurement pathways — all from a customer perspective and validated with German clinical, care, reimbursement, and procurement experts.
By the end of this , you will understand the market opportunity and have initiated engagement with your first German reference accounts for local validation and documentation.
Clinical validation is the key to earning trust in the German healthcare market. It proves that your solution is safe, effective, and ready for real-world use. Clear documentation turns that evidence into a language procurement teams understand.
It helps hospitals, insurers, and public buyers assess risk, compliance, and value.
Together with our experts we can plan, execute and manage your clinical activities in Germany.
The German inpatient and outpatient reimbursement system is complex, highly regulated, and often difficult to navigate.
Different pathways, stakeholders, evidence requirements, and timelines must be carefully aligned. With our hands-on market access experience, we help companies understand which route is most promising. Together with our network and partnerships with leading insurers, we validate options directly with key decision-makers.
This allows us to identify the best short-, mid-, and long-term reimbursement opportunities.
The result is a clear, actionable reimbursement roadmap for sustainable market access in Germany.
Once clinical evidence has been collected and local reimbursement documentation is in place, successful adoption becomes the next priority. We support healthcare innovators in translating evidence and reimbursement readiness into real-world clinical use. Together with German clinical and care experts, we define practical adoption pathways and implementation requirements. This includes adapting workflows, stakeholder communication, and training needs to local care settings.
By referring to established and new protocols, we help accelerate acceptance among providers and payers.
The result is a structured adoption roadmap that turns reimbursement potential into sustainable market uptake.
Once reference centers and local protocols are established, we support the next phase: scalable market expansion. Our nurse educators and clinical application specialists train new prospects by sharing real-world experience and clinical expertise. This helps accelerate adoption, build confidence, and transfer proven implementation models into new care settings.
We also support onboarding of local distributors, partners, and commercial teams.
Where needed, we help set up your local organization or identify strategic licensing opportunities.
The result is a scalable go-to-market model built on validated references, local know-how, and trusted clinical execution.
Through our CHIP initiative — Connected Health Innovation Powerhouses in Europe — we connect German health and life science clusters with leading European ecosystems and academic centers. Together with our partners, we create a pan-European network that links innovation, academia, industry, healthcare, and capital.
We are proud to collaborate with StartUp Factory GOe Future, LifeScience Factory by Sartorius, hannoverimpuls, SweCare, Vinnova, Sahlgrenska Science Park, Hightech Campus XXL, and Copenhagen HealthTech Hub. This network gives innovators access to trusted partners, expert knowledge, and cross-border market opportunities. By connecting regional strengths across Europe, we help accelerate validation, adoption, and scaling of healthcare innovation.
Mediq Connect turns fragmented ecosystems into one connected European launch and growth platform.
mediq Innovation Experts is your trusted partner helping health innovators enter, navigate and scale in the German and European healthcare markets. It brings together senior strategists, KOLs, health economists and regulatory/market access specialists to guide innovations from early validation to reimbursed use in routine care.
We stay until your solution works in real clinical practice.
We design pathways that payers, regulators and clinicians can say yes to.
We build your case together with leading hospitals, payers and end users.
We are the long‑term bridge between innovators and healthcare systems.
You work directly with senior experts who are hands-on in delivery.
High‑impact teams of complementary specialists across strategy, clinical practice, regulation, health economics and commercialization
We design clinical, reimbursement and commercial pathways so that innovations can enter routine care and long-term adaption
We combine clinical evidence, health economic arguments and a clear route to reimbursement
Strong and established network across hospitals, clinics, KOLs, payers and partners – enabling fast, high‑quality access to the German healthcare market
We translate strategies into concrete pilots, projects and processes – and stay involved until solutions work reliably in day‑to‑day operations in routine care
Leave your details and we’ll be in touch soon to explore if and how a collaboration with us can accelerate your next steps in the German healthcare market.
